文献速递妇科

经腹超声改善局部晚期宫颈癌腔内近距离放疗置管质量与剂量的III期随机试验

A phase III randomised trial of trans-abdominal ultrasound in improving application quality and dosimetry of intra-cavitary brachytherapy in locally advanced cervical cancer.
PubMed 文献 · Gynecol Oncol · 2020-12-06

这项III期开放标签随机对照试验纳入160例浸润性宫颈癌患者,比较经腹超声引导与无超声引导下腔内近距离放疗。超声组子宫穿孔率1.25%(n=1),非超声组12.5%(n=10)(p=0.005);超声组手术时间从26分钟缩短至19分钟(p=0.001),且危及器官受量显著降低。

要点

  • 经腹超声引导可显著降低子宫穿孔率(1.25% vs 12.5%,p=0.005)
  • 超声引导将手术时间从26分钟缩短至19分钟(p=0.001)
  • 超声引导下危及器官受量显著降低,应常规用于腔内近距离放疗

核心结论

  • 经腹超声引导可显著改善腔内近距离放疗的置管质量与剂量学,并缩短手术时间。
  • 作者建议经腹超声应常规用于腔内近距离放疗,尤其在资源有限环境中。

研究设计与样本

  • III期开放标签随机对照试验,纳入浸润性宫颈癌患者。
  • 采用计算机生成的简单随机化图表,将患者分为A组(无超声引导)和B组(超声引导下腔内近距离放疗)。
  • 共随机化160例患者。

主要发现

  • 超声组子宫穿孔率为1.25%(n=1),非超声组为12.5%(n=10)(p=0.005)。
  • 超声组完成整个手术的平均时间从26分钟显著缩短至19分钟(p=0.001)。
  • 剂量学评估显示,超声引导下各危及器官受量显著降低。

关键数值与推荐

  • 子宫穿孔率:超声组1.25%(n=1)vs 非超声组12.5%(n=10),p=0.005。
  • 平均手术时间:超声组19分钟 vs 非超声组26分钟,p=0.001。
  • 采用Fischer精确检验比较组间差异,p<0.05认为有统计学意义。

临床怎么用

  • 经腹超声引导应常规用于宫颈癌腔内近距离放疗的置管过程。
  • 在资源有限环境中,经腹超声引导尤其应优先采用以降低穿孔风险和危及器官受量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Intra-cavitary brachytherapy (ICB) remains an integral part of radiotherapy treatment in cervical cancer. Two-dimensional X ray point-based planning remains common and blind insertion leads to uterine perforations and higher toxicity. We conducted a randomised controlled trial of using trans-abdominal ultrasound in performing ICB to reduce perforation and organ at risk doses. PATIENT AND METHODS: The present study is a phase III open label randomised controlled trial of ultrasound guided ICB conducted on invasive cervical cancer patients. Patients were randomised by a simple computer-generated randomization chart into Arm A (No Ultrasound guidance) and Arm B (ICB with ultrasound guidance). The uterine perforation rates, tandem length change rates, bladder doses, rectal dose and procedure times were compared. Fischer exact test was used to compare the arms and p value <0.05 considered significant. RESULTS: A total of 160 patients were randomised. With US assistance, the uterine perforation rate was 1.25% (n = 1). In the non-US assistance arm the perforation rate was 12.5% (n = 10) (p = 0.005). Mean time to complete the entire procedure was significantly shortened from 26 min to 19 min favouring the US arm (p = 0.001). Dosimetric assessment between the two groups showed significant decrease in dose received by the various organs at risk with US assistance. CONCLUSION: The present study confirms significant improvement in application quality as well as dosimetry with reduction in procedure time. Trans-Abdominal US should be routinely used for ICB procedures, particularly in resource limited settings.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Pareek V, Barthwal M, Giridhar P, et al. A phase III randomised trial of trans-abdominal ultrasound in improving application quality and dosimetry of intra-cavitary brachytherapy in locally advanced cervical cancer. Gynecol Oncol. 2020. PMID: 33293047. doi:10.1016/j.ygyno.2020.11.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。